Add to Favorites Newsroom RSS Share
fb-shareUniversity of Texas M. D. Anderson Cancer Center
Houston, TX USA

Our News on Newswise

Pemmaraju.jpg

Study of Tagraxofusp Reports 90 Percent Response Rate for Deadly Blood Cancer with No Prior Available Therapies

An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD Anderson Cancer Center, reports that treatment with the drug tagraxofusp resulted in high response rates in patients with blastic plasmacytoid dendritic...
24-Apr-2019 9:00 AM EDT Add to Favorites

201489_Piwnica-Worms_R.jpg

Triple negative breast cancers can adopt reversible state that is resistant to chemotherapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather...
17-Apr-2019 12:05 PM EDT Add to Favorites

Single agent umbralisib effective for relapsed slow-growing lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma (MZL). Findings from the Phase II trial were presented by study...
31-Mar-2019 10:05 AM EDT Add to Favorites

GiulioDraetta.jpg

New potential therapeutic target for pancreatic cancer discovered

Cancer cells demand enormous amounts of molecular “food” to survive and grow, and a study published March 27 online in Nature by researchers at The University of Texas MD Anderson Cancer Center may have identified a new approach to starve the...
26-Mar-2019 2:05 PM EDT Add to Favorites

203533_Wargo_J.jpg

MD Anderson study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer

White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade (ICB) therapy, according to a study at The University of Texas MD Anderson Cancer Center. Study...
25-Mar-2019 10:05 AM EDT Add to Favorites

DePinhoRonald450x675.jpg

MD Anderson study points to new strategy for boosting immunotherapy effectiveness in advanced colorectal cancer

Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS as a possible explanation for why many patients with metastatic colorectal cancer (CRC) do not respond to immune checkpoint blockade (ICB) therapy.
20-Mar-2019 2:05 PM EDT Add to Favorites

New Report Finds States Must Do More to Ensure People at High Risk Can Be Screened for Lung Cancer

MD Anderson and the American Lung Association have partnered on educational initiatives to improve coverage for recommended lung cancer screening in state Medicaid programs.
19-Mar-2019 10:00 AM EDT Add to Favorites

don_gibbons.jpg

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer

A cellular identity switch protects a cancer-promoting genetic pathway from targeted therapy, researchers at The University of Texas MD Anderson Cancer Center today reported in Science Translational Medicine. Working in cell lines and mouse...
13-Mar-2019 3:05 PM EDT Add to Favorites


see all news

Our Experts on Newswise

BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

see all experts

Our YouTube Videos

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Contacts

Clayton Boldt

crboldt@mdanderson.org

713-792-9518

Katrina Burton
Senior Communications Specialist

kburton@mdanderson.org

713-792-8034

Leslie Friedman
Communications professional

LKFriedman@mdanderson.org

713-563-9340

Scott Merville
Program Manager

smerville@mdanderson.org

713-792-0661

Julie Penne
Assistant Director

jpenne@mdanderson.org

713-792-0662

Allison Schaffer
Senior Communications Specialist

ASchaffer@mdanderson.org

713-745-1357

Twitter twitter-icon

Chat now!